Taiwan
· Delayed Price · Currency is TWD Adimmune Company Description
Adimmune Corporation engages in the development, manufacture, and distribution of vaccines and other biological products in Taiwan, the United States, China, and internationally.
It offers AdimFlu-S, a quadrivalent influenza vaccine; tetanus toxoid alum precipitated product that is used for the prevention of tetanus after injury; Japanese encephalitis vaccines; Trivalent influenza vaccines; Quadrivalent influenza vaccine; Influenza A (H1N1) Virus Monovalent Vaccine; and purified Tuberculin, as well as contract manufacturing services.
The company was formerly known as Kuo Kwang Serum and Vaccine Manufacture Co., Ltd. and changed its name to Adimmune Corporation in 2001.
Adimmune Corporation was incorporated in 1965 and is headquartered in Taichung, Taiwan.
| Country | Taiwan |
| Founded | 1965 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 564 |
| CEO | Chi-Hsien Chan |
Contact Details
Address: No. 3, Tanxing Road Taichung, 427003 Taiwan | |
| Phone | 886 4 2538 1220 |
| Website | adimmune.com.tw |
Stock Details
| Ticker Symbol | 4142 |
| Exchange | Taiwan Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0004142005 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Chi-Hsien Chan | Chief Executive Officer and Chairman |
| Chung-Cheng Liu | President, GM and Director |
| Chin-Chuan Chang | Chief Operating Officer and Vice President of Research & Development |
| Fei Pan | Chief Legal Officer and General Counsel |
| Dr. Chun Cheng Chen M.B.A., M.D., M.Sc., Ph.D. | Chief Medical Officer |
| Yin-Teng Chang | Chief Financial Officer |
| Li-Ya Tang | Director of Administration Center |
| Chih-Hsiang Leng | Head of Research & Development Division |
| Chin-I Chiu | Vice President of Quality Assurance Department |